Journey Advisory Group Portfolio holdings
Top Buys
| 1 |
American Tower
AMT
|
+$2.03M |
| 2 |
Schwab Short-Term US Treasury ETF
SCHO
|
+$1.27M |
| 3 |
Vanguard Total Bond Market
BND
|
+$1.17M |
| 4 |
JPMorgan Ultra-Short Income ETF
JPST
|
+$1.08M |
| 5 |
Apple
AAPL
|
+$630K |
Top Sells
| 1 |
Clorox
CLX
|
+$1.69M |
| 2 |
Ecolab
ECL
|
+$778K |
| 3 |
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
|
+$534K |
| 4 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$306K |
| 5 |
Invesco Preferred ETF
PGX
|
+$236K |
Sector Composition
| 1 | Technology | 16.2% |
| 2 | Healthcare | 9.91% |
| 3 | Consumer Staples | 7.95% |
| 4 | Financials | 7.81% |
| 5 | Industrials | 6.13% |
Similar funds
Journey Advisory Group's Q2 2021 Portfolio in Review
As of Q2 2021, Journey Advisory Group held 205 positions worth $315M, up 10% from $286M the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Journey Advisory Group deployed $12M of net new capital in Q2 2021, opening 11 new positions and adding to 89 existing holdings. Its largest new stake was FMC: 2,643 shares worth $286K.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Staples.
On the sell side, the largest reduction was PIMCO Enhanced Short Maturity Active Exchange-Traded Fund, an estimated $534K trimmed.
- Journey Advisory Group's largest Q2 2021 buy was FMC: 2,643 shares worth $286K.
- Journey Advisory Group added most to American Tower in Q2 2021, an estimated $2.03M increase.
- Journey Advisory Group's biggest Q2 2021 reduction was PIMCO Enhanced Short Maturity Active Exchange-Traded Fund, cutting an estimated $534K.
- Journey Advisory Group fully exited Clorox in Q2 2021, selling an estimated $1.69M.
- Journey Advisory Group's ten largest holdings make up 34% of its $315M portfolio in Q2 2021.
- Journey Advisory Group opened 11 new positions and closed 4 in Q2 2021.
- Journey Advisory Group's portfolio value rose 10% quarter-over-quarter to $315M.
Based on Journey Advisory Group's 13F filing for Q2 2021, filed 13 Aug 2021.